DnaJA2 activators encompass a class of chemical agents that target the DnaJA2 protein, a member of the Hsp40 (Heat Shock Protein 40) family, which acts as a co-chaperone in the molecular chaperone system. DnaJA2, specifically, is known to interact with Hsp70, assisting in the proper folding of nascent polypeptides, the refolding of misfolded proteins, and the prevention of protein aggregation. This interaction is critical for maintaining cellular proteostasis, particularly under stress conditions where the demand for protein quality control is heightened.
The activation of DnaJA2 by these chemical agents can be direct or indirect. Direct activators bind to DnaJA2, inducing a conformational change that enhances its interaction with Hsp70, thus boosting its co-chaperone activity. This can increase the efficiency of the Hsp70 system in protein folding and repair, which is a process of fundamental importance in cellular function and response to stress. Indirect activators, on the other hand, may not bind directly to DnaJA2 but may influence other cellular pathways that lead to the upregulation of DnaJA2 expression or activity. They could stimulate the transcription of the DnaJA2 gene or stabilize its mRNA, leading to an increase in protein synthesis. Furthermore, these activators might enhance post-translational modifications of DnaJA2 that are necessary for its functionality or could activate signaling cascades that result in the increased association of DnaJA2 with Hsp70.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Geldanamycin is an inhibitor of heat shock protein 90 (Hsp90). By inhibiting Hsp90, it can promote the activity of co-chaperones like DnaJA2 in assisting protein folding. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
17-AAG is another Hsp90 inhibitor. Its inhibition of Hsp90 can indirectly enhance the functional activity of DnaJA2 by increasing the demand for DnaJA2's protein folding assistance. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $90.00 $326.00 | 13 | |
Radicicol is an Hsp90 inhibitor. By inhibiting Hsp90, it enhances the role of DnaJA2 in chaperone-mediated protein folding. | ||||||
Novobiocin | 303-81-1 | sc-362034 sc-362034A | 5 mg 25 mg | $96.00 $355.00 | ||
Novobiocin is also an Hsp90 inhibitor. Its inhibition of Hsp90 can indirectly enhance the functional activity of DnaJA2 in protein folding. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $110.00 $386.00 | 8 | |
Oxaliplatin is a platinum-based drug that causes DNA damage and can increase the demand for DnaJA2's role in repairing misfolded proteins. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin is another platinum-based drug that causes DNA damage, increasing the demand for DnaJA2's role in protein folding and repair. | ||||||
Carboplatin | 41575-94-4 | sc-202093 sc-202093A | 25 mg 100 mg | $47.00 $132.00 | 14 | |
Carboplatin, a platinum-based drug, can cause DNA damage and increase the functional activity of DnaJA2 in protein repair. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Fluorouracil is an antimetabolite that disrupts RNA and DNA synthesis, potentially enhancing the demand for DnaJA2's role in protein folding and repair. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide is a topoisomerase inhibitor that can cause DNA damage and enhance the demand for DnaJA2's function in protein folding and repair. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin is a DNA intercalating agent that can cause DNA damage and enhance the demand for DnaJA2's role in protein folding and repair. |